AMANDA FOX: Open Payments
NPI 1922683655 · PALMER, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$861 in 36 payments from 12 companies in 2025. Trend: 2023 $1,300 · 2024 $1,398 · 2025 $861
Food & beverage: $861
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $181 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $129 |
| Amgen Inc. | 5 | $125 |
| ABBVIE INC. | 4 | $104 |
| Sumitomo Pharma America, Inc. | 4 | $86 |
| Lilly USA, LLC | 2 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $48 |
| Digestive Care, Inc. | 1 | $31 |
| GlaxoSmithKline, LLC. | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
Products named: CAPLYTA, EVENITY, AIRSUPRA, VRAYLAR, GEMTESA, FARXIGA, MOUNJARO, XIFAXAN.
Industry payments across AK — which companies pay providers there.
